Table 2 Multivariable logistic regression model for prediction of marked and moderate LUTS improvement after robot-assisted radical prostatectomy in patients with moderate or severe preoperative LUTS.

From: Improvement of quality of life and symptom burden after robot-assisted radical prostatectomy in patients with moderate to severe LUTS

Value

Marked LUTS improvement

∆IPSS ≤ − 8

Moderate LUTS improvement

∆IPSS − 5

ORa

95% CI

p-value

ORa

95% CI

p-value

Age, years, cont.

0.98

0.97–0.99

0.007

0.98

0.96–0.99

0.003

BMI, kg/m2, cont.

0.94

0.92–0.97

 < 0.001

0.96

0.94–0.99

0.003

Preoperative LUTS burden (severe vs. moderate [REF.])

15.6

10.4–23.4

 < 0.001

9.7

5.6–16.9

 < 0.001

Prostate gland weight, cont. (per 10 g)

1.12

1.07–1.16

 < 0.001

1.18

1.12–1.24

 < 0.001

Urinary continence recovery within 12 months after RARP, cont.

1.66

1.25–2.21

 < 0.001

1.84

1.40–2.40

 < 0.001

  1. CAPRA-S: the postsurgical Cancer of the Prostate Risk Assessment score; IPSS: International Prostate Symptom Score; LUTS: lower urinary tract symptoms; RARP: robot-assisted radical prostatectomy.
  2. aAdjusted for surgical experience, preoperative PSA, preoperative medication with alpha-blockers, 5-alpha-reductase inhibitors, neoadjuvant androgen deprivation, CAPRA-S score, nerve-sparing status and bladder neck reconstruction width.
Back to article page